Gracell Biotechnologies Inc. American Depositary Shares

GRCL

...

GRCL: Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer. The company aims to disrupt conventional approaches to CAR-T cell therapies with its proprietary technology platforms-FasTCAR and TruUCAR.

Show GRCL Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of GRCL by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by GRCL's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on GRCL's company Twitter account

WallStreetBets

Number of mentions of GRCL in WallStreetBets Daily Discussion

GRCL News

Recent insights relating to GRCL

CNBC Recommendations

Recent picks made for GRCL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GRCL

Corporate Flights

Flights by private jets registered to GRCL